NYSE:HIMS

Hims & Hers Health (HIMS) Stock Forecast, Price & News

$6.22

+0.06 (+0.97%)

(As of 09/27/2023 ET)

Compare

Today's Range: $6.08
▼
$6.32
50-Day Range: $6.02
▼
$8.97
52-Week Range: $4.01
▼
$12.34

Volume: 1.27 million shs
Average Volume: 1.92 million shs
Market Capitalization: $1.31 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $11.75

Hims & Hers Health MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.70 Rating Score
Upside/Downside: 88.9% Upside
$11.75 Price Target
Short Interest: Bearish
12.38% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.18
Based on 6 Articles This Week
Insider Trading: Selling Shares
$2.25 M Sold Last Quarter
Proj. Earnings Growth: Growing
From ($0.15) to ($0.07) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.00 out of 5 stars

Medical Sector

629th out of 976 stocks

Offices & Clinics Of Medical Doctors Industry

3rd out of 7 stocks

3.4

Analyst's Opinion

Consensus Rating
Hims & Hers Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 7 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $11.75, Hims & Hers Health has a forecasted upside of 88.9% from its current price of $6.22.
Amount of Analyst Coverage
Hims & Hers Health has only been the subject of 3 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
12.38% of the float of Hims & Hers Health has been sold short.
Short Interest Ratio / Days to Cover
Hims & Hers Health has a short interest ratio ("days to cover") of 5.9.
Change versus previous month
Short interest in Hims & Hers Health has recently increased by 0.48%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Hims & Hers Health does not currently pay a dividend.
Dividend Growth
Hims & Hers Health does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HIMS.

1.6

News and Social Media Coverage

News Sentiment
Hims & Hers Health has a news sentiment score of -0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Hims & Hers Health this week, compared to 4 articles on an average week.
Search Interest
Only 11 people have searched for HIMS on MarketBeat in the last 30 days. This is a decrease of -61% compared to the previous 30 days.
MarketBeat Follows
21 people have added Hims & Hers Health to their MarketBeat watchlist in the last 30 days. This is an increase of 91% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Hims & Hers Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,245,169.00 in company stock.
Percentage Held by Insiders
31.63% of the stock of Hims & Hers Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
61.45% of the stock of Hims & Hers Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Hims & Hers Health are expected to grow in the coming year, from ($0.15) to ($0.07) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Hims & Hers Health is -28.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Hims & Hers Health is -28.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Hims & Hers Health has a P/B Ratio of 4.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Hims & Hers Health (NYSE:HIMS) Stock

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

HIMS Price History

30 days | 90 days | 365 days | Advanced Chart

HIMS Stock News Headlines

September 19, 2023 | marketbeat.com

2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally

Beauty stocks have not been pretty this year. Cosmetics retailer Ulta Beauty Inc. (NASDAQ: ULTA) and Estee Lauder Co. (NYSE: EL) shares

September 25, 2023 | seekingalpha.com

Hims & Hers Health: Can't Get Much Better

September 28, 2023 | Edge On The Street (Ad)

The Strategic Gold Play You Haven't Heard About

Experts recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure.

September 25, 2023 | americanbankingnews.com

Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $42,666.32 in Stock

September 22, 2023 | msn.com

Hims and Hers Stock Analysis: Buy or Sell?

September 21, 2023 | msn.com

Hims & Hers: Myopic Shorts, Absurdly Cheap

September 21, 2023 | msn.com

Hims & Hers Health: Risks Remain, But Upgrading To Buy

September 18, 2023 | msn.com

The Market Is Wrong On Hims & Hers Health

September 28, 2023 | Wall Street Fundamentals (Ad)

Would Buffett Approve of This Growth Strategy?

Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.

September 6, 2023 | finance.yahoo.com

Hims & Hers Named on Fortune Media and Great Place to Work’s 2023 Best Workplaces in Health Care List

September 6, 2023 | msn.com

Is This Underrated SPAC Deal Stock a No-Brainer Buy?

August 24, 2023 | finance.yahoo.com

With 60% institutional ownership, Hims & Hers Health, Inc. (NYSE:HIMS) is a favorite amongst the big guns

August 21, 2023 | msn.com

Hims & Hers: Buying With Both Fists (Double Rating Upgrade)

August 16, 2023 | seekingalpha.com

Hims & Hers Q2 Earnings: Portfolio Cure

August 16, 2023 | msn.com

Hims & Hers: Divergence Between Fundamentals And Valuation

August 15, 2023 | msn.com

Hims & Hers: Niche Telehealth Player With Huge Potential

August 15, 2023 | seekingalpha.com

Hims & Hers: The Current Weakness Creates A Buying Opportunity

August 9, 2023 | forbes.com

Hims (ED) Review 2023

August 9, 2023 | msn.com

Truist Securities Maintains Hims & Hers Health Inc - (HIMS) Hold Recommendation

August 9, 2023 | finance.yahoo.com

Hims & Hers Health, Inc. (NYSE:HIMS) Q2 2023 Earnings Call Transcript

August 9, 2023 | msn.com

Is Hims & Hers Health Stock a Must Buy Under $10?

August 9, 2023 | markets.businessinsider.com

Truist Financial Sticks to Their Hold Rating for Hims & Hers Health (HIMS)

August 9, 2023 | markets.businessinsider.com

Hims & Hers Health Reports Q2 Earnings, Beating Top And Bottom Lines, Raises Guidance

August 8, 2023 | msn.com

Hims & Hers Will Offer Weight-Loss Drugs, But Not the Ones You Are Thinking Of

August 8, 2023 | msn.com

Hims & Hers Health Stock (NYSE:HIMS): An Opportunity to Get Your Blood Pumping

August 8, 2023 | msn.com

Credit Suisse Reiterates Hims & Hers Health Inc - (HIMS) Outperform Recommendation

August 8, 2023 | finance.yahoo.com

Q2 2023 Hims & Hers Health Inc Earnings Call

See More Headlines

Receive HIMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hims & Hers Health and its competitors with MarketBeat's FREE daily newsletter.

HIMS Company Calendar

Last Earnings: 8/07/2023
Today: 9/28/2023
Next Earnings (Estimated): 11/06/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Offices & clinics of medical doctors
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:HIMS
CUSIP: N/A
CIK: 1773751
Web: www.forhims.com
Phone: 415-851-0195
Fax: N/A
Employees: 651
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $11.75
High Stock Price Forecast: $18.00
Low Stock Price Forecast: $5.00
Forecasted Upside/Downside: +88.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.70
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.22)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-65,680,000.00
Net Margins: -6.61%
Pretax Margin: -6.58%
Return on Equity: -14.97%
Return on Assets: -12.40%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.53
Quick Ratio: 3.20

Sales & Book Value

Annual Sales: $526.92 million
Price / Sales: 2.49
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.50 per share
Price / Book: 4.15

Miscellaneous

Outstanding Shares: 211,020,000
Free Float: 144,276,000
Market Cap: $1.31 billion
Optionable: Optionable
Beta: 0.53

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Andrew Dudum (Age 34)
Co-Founder, Chairman & CEO
Comp: $1.7M

Mr. Yemi Okupe (Age 37)
Chief Financial Officer
Comp: $804.05k

Ms. Melissa Baird (Age 45)
Chief Operating Officer
Comp: $917.67k

Ms. Irene A. Becklund (Age 38)
Sr. VP, Controller & Principal Accounting Officer
Comp: $361.12k

Ms. Soleil Teubner Boughton (Age 44)
Chief Legal Officer & Corp. Sec.
Comp: $782.66k

Mr. Mike Chi (Age 43)
Chief Marketing Officer
Comp: $514.77k

Dr. Patrick Carroll M.D. (Age 65)
Chief Medical Officer, Member of Medical Advisory Board & Director
Comp: $27.03k

Mr. Brian O'Shaughnessy
Chief Communications Officer

Ms. Amee Parekh
Sr. VP of HR

Mr. Jonathan Spitzer C.F.A.
Sr. VP of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HIMS Stock - Frequently Asked Questions

Should I buy or sell Hims & Hers Health stock right now?: 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hims & Hers Health in the last year. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HIMS shares.
View HIMS analyst ratings or view top-rated stocks.
What is Hims & Hers Health's stock price forecast for 2023?: 10 brokers have issued 12-month target prices for Hims & Hers Health's stock. Their HIMS share price forecasts range from $5.00 to $18.00. On average, they predict the company's stock price to reach $11.75 in the next twelve months. This suggests a possible upside of 88.9% from the stock's current price.
View analysts price targets for HIMS or view top-rated stocks among Wall Street analysts.
How have HIMS shares performed in 2023?: Hims & Hers Health's stock was trading at $6.41 at the beginning of the year. Since then, HIMS shares have decreased by 3.0% and is now trading at $6.22.
View the best growth stocks for 2023 here.
Are investors shorting Hims & Hers Health?: Hims & Hers Health saw a decrease in short interest in the month of August. As of August 31st, there was short interest totaling 16,650,000 shares, a decrease of 5.8% from the August 15th total of 17,680,000 shares. Based on an average daily trading volume, of 2,990,000 shares, the short-interest ratio is presently 5.6 days. Approximately 12.4% of the company's stock are short sold.
View Hims & Hers Health's Short Interest.
When is Hims & Hers Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our HIMS earnings forecast.
How were Hims & Hers Health's earnings last quarter?: Hims & Hers Health, Inc. (NYSE:HIMS) issued its earnings results on Monday, August, 7th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.03. The business had revenue of $207.91 million for the quarter, compared to analyst estimates of $204.95 million. Hims & Hers Health had a negative net margin of 6.61% and a negative trailing twelve-month return on equity of 14.97%. The business's revenue was up 83.1% on a year-over-year basis. During the same period in the previous year, the company earned ($0.10) earnings per share.
What ETFs hold Hims & Hers Health's stock?: ETFs with the largest weight of Hims & Hers Health (NYSE:HIMS) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Global X Telemedicine & Digital Health ETF (EDOC), Alpha Architect U.S. Quantitative Momentum ETF (QMOM), Amplify Online Retail ETF (IBUY), Fidelity Digital Health ETF (FDHT) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has Hims & Hers Health issued on next quarter's earnings?: Hims & Hers Health issued an update on its third quarter 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $217.00 million-$222.00 million, compared to the consensus revenue estimate of $213.78 million.
What is Hims & Hers Health's stock symbol?: Hims & Hers Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HIMS."
Who are Hims & Hers Health's major shareholders?: Hims & Hers Health's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.74%), Marshall Wace LLP (2.78%), State Street Corp (1.42%), Nuveen Asset Management LLC (1.37%), Nuveen Asset Management LLC (1.37%) and Geode Capital Management LLC (1.13%). Insiders that own company stock include Alex Bard, Andrew Dudum, David B Wells, David B Wells, Irene Becklund, Jack Abraham, Jules A Maltz, Lynne Chou O'keefe, Melissa Baird, Oluyemi Okupe, Patrick Harrison Carroll, Soleil Boughton and Spencer Lee.
View institutional ownership trends.
How do I buy shares of Hims & Hers Health?: Shares of HIMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Hims & Hers Health's stock price today?: One share of HIMS stock can currently be purchased for approximately $6.22.
How much money does Hims & Hers Health make?: Hims & Hers Health (NYSE:HIMS) has a market capitalization of $1.31 billion and generates $526.92 million in revenue each year. The company earns $-65,680,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis.
How many employees does Hims & Hers Health have?: The company employs 651 workers across the globe.
How can I contact Hims & Hers Health?: Hims & Hers Health's mailing address is 2269 CHESTNUT STREET SUITE 523, SAN FRANCISCO CA, 94123. The official website for the company is www.forhims.com. The company can be reached via phone at 415-851-0195 or via email at hims-ir@westwicke.com.

This page (NYSE:HIMS) was last updated on 9/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Hims & Hers Health (HIMS) Stock Forecast, Price & News

Hims & Hers Health MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Hims & Hers Health (NYSE:HIMS) Stock

HIMS Price History

HIMS Stock News Headlines

HIMS Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

HIMS Stock - Frequently Asked Questions

Overall MarketRank^™